|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2000-6-15
|
|
pubmed:abstractText |
To determine whether the addition of rifampin to a quinolone-based antibacterial prophylactic regimen in patients undergoing high-dose chemotherapy (HDC) with peripheral-blood stem-cell transplantation (PBSCT) decreases the incidence of neutropenia and fever, Gram-positive bacteremia, and infection-related morbidity.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:ArcedianoAA,
pubmed-author:Cortés-FunesHH,
pubmed-author:Gomez-MartinCC,
pubmed-author:HidalgoMM,
pubmed-author:HornedoJJ,
pubmed-author:LumbrerasCC,
pubmed-author:PerduDD,
pubmed-author:RodriguezMM,
pubmed-author:SalazarRR,
pubmed-author:SoláCC,
pubmed-author:ValentíVV
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2126-34
|
|
pubmed:dateRevised |
2005-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10811678-Adult,
pubmed-meshheading:10811678-Anti-Bacterial Agents,
pubmed-meshheading:10811678-Anti-Infective Agents,
pubmed-meshheading:10811678-Antibiotics, Antitubercular,
pubmed-meshheading:10811678-Antineoplastic Agents,
pubmed-meshheading:10811678-Ciprofloxacin,
pubmed-meshheading:10811678-Drug Therapy, Combination,
pubmed-meshheading:10811678-Female,
pubmed-meshheading:10811678-Fever,
pubmed-meshheading:10811678-Gram-Positive Bacterial Infections,
pubmed-meshheading:10811678-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:10811678-Humans,
pubmed-meshheading:10811678-Male,
pubmed-meshheading:10811678-Neoplasms,
pubmed-meshheading:10811678-Neutropenia,
pubmed-meshheading:10811678-Prospective Studies,
pubmed-meshheading:10811678-Rifampin,
pubmed-meshheading:10811678-Statistics, Nonparametric,
pubmed-meshheading:10811678-Treatment Outcome
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Rifampin does not improve the efficacy of quinolone antibacterial prophylaxis in neutropenic cancer patients: results of a randomized clinical trial.
|
|
pubmed:affiliation |
Division of Medical Oncology, Microbiology, and Infectious Disease, Hospital Universitario "12 de Octubre," Madrid, Spain.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study
|
